Skip to main content
Figure 3 | Malaria Journal

Figure 3

From: The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment

Figure 3

Visual predictive checks of the final two-compartment-model describing the population pharmacokinetics of lumefantrine. The aforementioned visual predictive checks are for HIV-malaria co-infected patients on NVP-based ART (NVP-arm), EFV-based ART (EFV-arm) and those not yet on antiretroviral therapy (control-arm) treated with artmether-lumefantrine.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us